We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Removal of Ovarian Tumors Should Be Accompanied by Appendectomy

By HospiMedica International staff writers
Posted on 29 Dec 2010
A new study indicates that appendectomy may be needed along with oophorectomy for women undergoing surgery for suspected ovarian neoplasm.

Researchers at the University of Virginia Health System (UVHS, Charlottesville, USA) conducted a retrospective analysis of 191 patients who underwent oophorectomy and appendectomy during the same surgical procedures at the UVHS between 1992 to 2007, to investigate the prevalence of appendiceal pathology in women undergoing surgery for a suspected ovarian neoplasm, and the predictive value of intraoperative findings to determine the need for concurrent appendectomy. More...
Observations were stratified based on the nature (benign, borderline, or malignant) and histology (serous compared with mucinous) of the ovarian neoplasm, frozen compared with final pathological diagnosis, and the gross appearance of the appendix.

The results showed that the high rates of coexisting appendiceal pathology were associated with serous ovarian cancers. This involved 94.4% of grossly abnormal and 35.3% of normal appendices. The same was true of ovarian tumors suspected to be of primary gastrointestinal origin, with 82.8% of grossly abnormal and 60% of normal appendices harboring coexisting mucinous neoplasms. Based on linear regression analysis, the researchers recommended appendectomy when frozen section diagnosis is mucinous or serous ovarian carcinoma, borderline tumor, or metastatic carcinoma of suspected gastrointestinal origin. The study was published in the December 2010 issue of Obstetrics and Gynecology.

"Ovarian cancers frequently spread to the appendix, and conversely small or even microscopic appendiceal tumors can metastasize to the ovaries and present as an ovarian mass,” said lead author Amir Jazaeri, MD. "There are situations where appendectomy is prudent even when the appendix looks completely normal because of risk of microscopic abnormalities. These situations include when the frozen section pathology of the ovarian mass reveals serous or mucinous cancers or so-called borderline -- low malignant potential -- ovarian tumors.”

Related Links:

University of Virginia Health System




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.